NMDA receptor antagonist-3
NMDA receptor antagonist-3, a NMDA receptor antagonist, stands out with a remarkable percentage of recovery (40.0%, at 100 μM) and safe toxicological profile in SH-SY5Y and human adipose mesenchymal stem cells.
Product Specifications
CAS Number
[2762181-52-0]
UNSPSC
12352005
Target
IGluR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/nmda-receptor-antagonist-3.html
Solubility
10 mM in DMSO
Smiles
O=C(CN)N1[C@@H](C2)CC[C@@H]2[C@@]1([H])C(N[C@H](C(O)=O)CC(O)=O)=O
Molecular Formula
C13H19N3O6
Molecular Weight
313.31
References & Citations
[1]Sampaio-Dias IE, et al. Design, Synthesis, and Biological Evaluation of Hybrid Glypromate Analogues Using 2-Azanorbornane as a Prolyl and Pipecolyl Surrogate. ACS Chem Neurosci. 2021 Oct 6;12 (19) :3615-3624.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
NMDA Receptor
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15150349 1 Vial
Lentiviral human RAD21L1 shRNA (UAS) - Lentiviral human RAD21L1 shRNA (UAS, RFP) plasmid
Ask
View Details 037296-ML490 100 µL
KCNA5, CT (KCNA5, Potassium voltage-gated channel subfamily A member 5, HPCN1, Voltage-gated potassium channel HK2, Voltage-gated potassium channel subunit Kv1.5) (MaxLight 490) discontinued
Ask
View Details RC220269A1V 250 µL
Human Lymphocyte Activation Gene 3 (LAG3) (NM_002286) AAV Particle
Ask
View Details 